Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis

NCT02317887 is registered in ClinicalTrials.gov with VegaVect, Inc. as lead sponsor.

NCT NCT02317887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02317887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis
Lead sponsor
VegaVect, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
February 11, 2015
Completion date
October 16, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinoschisis, x-linked